Thrombocytopenia News and Research

RSS
Thrombocytopenia is a condition in which there is a lower-than-normal number of platelets in the blood. It may result in easy bruising and excessive bleeding from wounds or bleeding in mucous membranes and other tissues.
Ionis announces FDA approval of first SMA drug in the U.S for pediatric and adult patients

Ionis announces FDA approval of first SMA drug in the U.S for pediatric and adult patients

FDA awards accelerated approval to new ovarian cancer drug

FDA awards accelerated approval to new ovarian cancer drug

Long-term clinical data, experience supports effectiveness of PRRT for treating neuroendocrine tumors

Long-term clinical data, experience supports effectiveness of PRRT for treating neuroendocrine tumors

Study finds blood thinning drugs derived from cattle and pigs have equivalent anti-clotting properties

Study finds blood thinning drugs derived from cattle and pigs have equivalent anti-clotting properties

Janssen seeks to extend DARZALEX license to benefit more multiple myeloma patients

Janssen seeks to extend DARZALEX license to benefit more multiple myeloma patients

Report: Zika cases soar in Puerto Rico

Report: Zika cases soar in Puerto Rico

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Salvage inotuzumab ozogamicin improves ALL outcomes

Salvage inotuzumab ozogamicin improves ALL outcomes

Long-term dasatinib findings support first-line use in CML

Long-term dasatinib findings support first-line use in CML

Discovery on new form ETV6-related thrombocytopenia presented at EHA Annual Congress

Discovery on new form ETV6-related thrombocytopenia presented at EHA Annual Congress

Air pollution exposure may have direct role in triggering lupus among children and adolescents

Air pollution exposure may have direct role in triggering lupus among children and adolescents

Unsafe antiplatelet use persists in PCI patients

Unsafe antiplatelet use persists in PCI patients

Clinical study shows improved outcomes for NET patients treated with Lutathera over Octreotide LAR

Clinical study shows improved outcomes for NET patients treated with Lutathera over Octreotide LAR

EPIC Results Shed Light On First-Line Ponatinib Risk-Benefit Profile

EPIC Results Shed Light On First-Line Ponatinib Risk-Benefit Profile

Phase 2 results of AbbVie’s venetoclax in patients with R/R CLL with 17p deletion published in The Lancet Oncology

Phase 2 results of AbbVie’s venetoclax in patients with R/R CLL with 17p deletion published in The Lancet Oncology

Bayer-new phase 3 liver cancer data

Bayer-new phase 3 liver cancer data

Study shows safety of experimental drug guadecitabine in colorectal cancer patients

Study shows safety of experimental drug guadecitabine in colorectal cancer patients

Magnesium could be safe, cost-effective therapeutic intervention for genetic coagulation disorder

Magnesium could be safe, cost-effective therapeutic intervention for genetic coagulation disorder

New FDA approval expands use of AstraZeneca's Faslodex for women with HR+, HER2- metastatic breast cancer

New FDA approval expands use of AstraZeneca's Faslodex for women with HR+, HER2- metastatic breast cancer

RUVICA (ibrutinib) capsules approved for treatment-naïve CLL patients

RUVICA (ibrutinib) capsules approved for treatment-naïve CLL patients